Immunogen, Inc.

ImmunoGen, Inc. is a biotechnology company that develops targeted anticancer therapeutics. The company combines its proprietary antibody-drug conjugate technology with its expertise in the tumor biology to design and develop novel treatments for various types of cancer. ImmunoGen's innovative approach aims to deliver potent cytotoxic agents directly to cancer cells while minimizing exposure to healthy tissues, thereby reducing side effects. With a commitment to improving patient outcomes, ImmunoGen is dedicated to advancing its pipeline of potential therapies and collaborating with partners to make a meaningful impact in the field of oncology.